NCT06116253Active, not recruiting
Advanced Diffusion Imaging in Renal Cancer Patients
Advanced Diffusion Imaging in Renal Cancer Patients: Oncologic Control and Renal Functional Reserve
Source: ClinicalTrials.gov · Last updated 8 May 2026
Brief summary (registry, in English)
The objective of this study is to apply advanced diffusion imaging in a two-pronged assessment of renal mass patients: (1) characterization of lesion malignancy and subtype, and (2) prediction of renal function stability or decline following partial nephrectomy.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 39 (actual)
- First submitted
- 31 Oct 2023
- Start date
- 1 Dec 2022
- Primary completion date
- 1 Dec 2028
- Lead sponsor
- NYU Langone Health
- Diseases
- Kidney cancer
- NCT number
- NCT06116253
What you commit to
- Study type: Interventional
- Participants enrolled: 39
- From 1 Dec 2022 to the primary completion date, 1 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- All metal implants and dental implants that have ferromagnetic properties and are unsafe at 3.0 T.
Other
- Pregnant women are not eligible for participating in this study.
- Acute claustrophobia
Who the study is looking for
- Renal mass patients scheduled for laparoscopic partial nephrectomy.
- eGFR above 30 ml/min/m2.
- Ages 21 to 85
- Must be willing and able to provide consent.
Age in the registry: 21 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NYU Langone Health Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.